SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Kristian Krpina, Emina Babarović, Nives Jonjić, Correlation of tumor-infiltrating lymphocytes with bladder cancer recurrence in patients with solitary low-grade urothelial carcinoma, Virchows Archiv, 2015,

    CrossRef

  2. 2
    Alexander Pedroza-Gonzalez, Guoying Zhou, Simar Pal Singh, Patrick P.C. Boor, Qiuwei Pan, Dirk Grunhagen, Jeroen de Jonge, T C Khe Tran, Cornelis Verhoef, Jan Nm Ijzermans, Harry L.A. Janssen, Katharina Biermann, Jaap Kwekkeboom, Dave Sprengers, GITR engagement in combination with CTLA-4 blockade completely abrogates immunosuppression mediated by human liver tumor-derived regulatory T cellsex vivo, OncoImmunology, 2015, 00

    CrossRef

  3. 3
    Gaetano Bertino, Shirin Demma, Annalisa Ardiri, Maria Proiti, Alessandra Mangia, Salvatore Gruttadauria, Adriana Toro, Isidoro Di Carlo, Giulia Malaguarnera, Nicoletta Bertino, Mariano Malaguarnera, Michele Malaguarnera, The Immune System in Hepatocellular Carcinoma and Potential New Immunotherapeutic Strategies, BioMed Research International, 2015, 2015, 1

    CrossRef

  4. 4
    Oxana V. Makarova-Rusher, José Medina-Echeverz, Austin G. Duffy, Tim F. Greten, The yin and yang of evasion and immune activation in HCC, Journal of Hepatology, 2015, 62, 6, 1420

    CrossRef

  5. 5
    Lars T. Joeckel, Phillip I. Bird, Blessing or curse? Proteomics in granzyme research, PROTEOMICS - Clinical Applications, 2014, 8, 5-6
  6. 6
    Laurissa Ouaguia, Dhafer Mrizak, Sarah Renaud, Olivier Moralès, Nadira Delhem, Control of the Inflammatory Response Mechanisms Mediated by Natural and Induced Regulatory T-Cells in HCV-, HTLV-1-, and EBV-Associated Cancers, Mediators of Inflammation, 2014, 2014, 1

    CrossRef

  7. 7
    Jianguo Wu, Hongyan Cui, Zhifeng Zhu, Li Wang, Hong Li, Desheng Wang, Effect of HIF1α on Foxp3 expression in CD4+CD25 T lymphocytes, Microbiology and Immunology, 2014, 58, 7
  8. 8
    Eman R. Youness, Mohamed El Nemr, F. S. Oraby, Nadia M. Ahmed, Mohamed A. Moghni, Hanan F. Aly, Hanaa H. Ahmed, Evaluation of Apoptotic Marker Bcl2, CD4+, Human Hepatocyte Growth Factor and Metalloproteinase-9 as Tumor Markers for Patients with Hepatocellular Carcinoma, Indian Journal of Clinical Biochemistry, 2014, 29, 3, 351

    CrossRef

  9. 9
    Beatrice Omusiro Ondondo, Fallen Angels or Risen Apes? A Tale of the Intricate Complexities of Imbalanced Immune Responses in the Pathogenesis and Progression of Immune-Mediated and Viral Cancers, Frontiers in Immunology, 2014, 5,

    CrossRef

  10. 10
    Wenxiu Zhao, Lei Zhang, Yaping Xu, Zhengqi Zhang, Guangli Ren, Kai Tang, Penghao Kuang, Bixing Zhao, Zhenyu Yin, Xiaomin Wang, Hepatic stellate cells promote tumor progression by enhancement of immunosuppressive cells in an orthotopic liver tumor mouse model, Laboratory Investigation, 2014, 94, 2, 182

    CrossRef

  11. 11
    Gaetano Bertino, Shirin Demma, Annalisa Ardiri, Maria Proiti, Salvatore Gruttadauria, Adriana Toro, Giulia Malaguarnera, Nicoletta Bertino, Michele Malaguarnera, Mariano Malaguarnera, Isidoro Di Carlo, Hepatocellular Carcinoma: Novel Molecular Targets in Carcinogenesis for Future Therapies, BioMed Research International, 2014, 2014, 1

    CrossRef

  12. You have free access to this content12
    Yoriko Nomura, Masayoshi Kage, Toshirou Ogata, Reiichirou Kondou, Hisafumi Kinoshita, Kouichi Ohshima, Hirohisa Yano, Influence of splenectomy in patients with liver cirrhosis and hypersplenism, Hepatology Research, 2014, 44, 10
  13. 13
    Benjamin Brinkhoff, Dmitrij Ostroumov, Jessica Heemcke, Norman Woller, Engin Gürlevik, Michael P. Manns, Thomas Longerich, Lars Zender, John T. Harty, Stefan Kubicka, Florian Kühnel, Thomas C. Wirth, Microsphere priming facilitates induction of potent therapeutic T-cell immune responses against autochthonous liver cancers, European Journal of Immunology, 2014, 44, 4
  14. 14
    Ying Sun, Dong Xi, Wen Ding, Faxi Wang, Haili Zhou, Qin Ning, Soluble FGL2, a novel effector molecule of activated hepatic stellate cells, regulates T-cell function in cirrhotic patients with hepatocellular carcinoma, Hepatology International, 2014, 8, 4, 567

    CrossRef

  15. 15
    Thomas C Wirth, Spontaneous and therapeutic immune responses in hepatocellular carcinoma: implications for current and future immunotherapies, Expert Review of Gastroenterology & Hepatology, 2014, 8, 1, 101

    CrossRef

  16. 16
    Alexander Pedroza-Gonzalez, Cornelis Verhoef, Jan N. M. Ijzermans, Maikel P. Peppelenbosch, Jaap Kwekkeboom, Joanne Verheij, Harry L. A. Janssen, Dave Sprengers, Activated tumor-infiltrating CD4+ regulatory T cells restrain antitumor immunity in patients with primary or metastatic liver cancer, Hepatology, 2013, 57, 1
  17. 17
    Roniel Cabrera, Gyongyi Szabo, Another armed CD4+ T cell ready to battle hepatocellular carcinoma, Hepatology, 2013, 58, 1
  18. 18
    Polyxeni P Doumba, Marilena Nikolopoulou, Ilias P Gomatos, Manousos M Konstadoulakis, John Koskinas, Co-culture of primary human tumor hepatocytes from patients with hepatocellular carcinoma with autologous peripheral blood mononuclear cells: study of their in vitro immunological interactions, BMC Gastroenterology, 2013, 13, 1, 17

    CrossRef

  19. 19
    Ruchi Shukla, Kyle R. Upton, Martin Muñoz-Lopez, Daniel J. Gerhardt, Malcolm E. Fisher, Thu Nguyen, Paul M. Brennan, J. Kenneth Baillie, Agnese Collino, Serena Ghisletti, Shruti Sinha, Fabio Iannelli, Enrico Radaelli, Alexandre Dos Santos, Delphine Rapoud, Catherine Guettier, Didier Samuel, Gioacchino Natoli, Piero Carninci, Francesca D. Ciccarelli, Jose Luis Garcia-Perez, Jamila Faivre, Geoffrey J. Faulkner, Endogenous Retrotransposition Activates Oncogenic Pathways in Hepatocellular Carcinoma, Cell, 2013, 153, 1, 101

    CrossRef

  20. 20
    Aseem Lal, Loretta Chan, Sandy DeVries, Koei Chin, Gary K. Scott, Christopher C. Benz, Yunn-Yi Chen, Frederic M. Waldman, E. Shelley Hwang, FOXP3-positive regulatory T lymphocytes and epithelial FOXP3 expression in synchronous normal, ductal carcinoma in situ, and invasive cancer of the breast, Breast Cancer Research and Treatment, 2013, 139, 2, 381

    CrossRef

  21. 21
    Michal Ganz, Gyongyi Szabo, Immune and inflammatory pathways in NASH, Hepatology International, 2013, 7, S2, 771

    CrossRef

  22. 22
    Junliang Fu, Zheng Zhang, Lin Zhou, Zhaorui Qi, Shaojun Xing, Jiyun Lv, Jianfei Shi, Baoyun Fu, Zhenwen Liu, Ji-Yuan Zhang, Lei Jin, Yulai Zhao, George K.K. Lau, Jingmin Zhao, Fu-Sheng Wang, Impairment of CD4+ cytotoxic T cells predicts poor survival and high recurrence rates in patients with hepatocellular carcinoma, Hepatology, 2013, 58, 1
  23. 23
    Han Wu, Pei Chen, Rui Liao, Yi-Wei Li, Yong Yi, Jia-Xing Wang, Xiao-Yan Cai, Hong-Wei He, Jian-Jun Jin, Yun-Feng Cheng, Jia Fan, Jian Sun, Shuang-Jian Qiu, Intratumoral regulatory T cells with higher prevalence and more suppressive activity in hepatocellular carcinoma patients, Journal of Gastroenterology and Hepatology, 2013, 28, 9
  24. 24
    Shunji Nagai, Marwan S. Abouljoud, Marwan Kazimi, Kimberly A. Brown, Dilip Moonka, Atsushi Yoshida, Peritransplant Lymphopenia Is a Novel Prognostic Factor in Recurrence of Hepatocellular Carcinoma After Liver Transplantation, Transplantation, 2013, 1

    CrossRef

  25. 25
    Tai-Wei Sun, Qiang Gao, Shuang-Jian Qiu, Jian Zhou, Xiao-Ying Wang, Yong Yi, Jie-Yi Shi, Yong-Feng Xu, Ying-Hong Shi, Kang Song, Yong-Sheng Xiao, Jia Fan, B7-H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence, Cancer Immunology, Immunotherapy, 2012, 61, 11, 2171

    CrossRef

  26. 26
    Fei Zhao, Firouzeh Korangy, Tim F. Greten, Cellular Immune Suppressor Mechanisms in Patients with Hepatocellular Carcinoma, Digestive Diseases, 2012, 30, 5, 477

    CrossRef

  27. 27
    S. Fiorino, S. Lorenzini, M. Masetti, G. Deleonardi, A.G. Grondona, T. Silvestri, E. Chili, P. Del Prete, L. Bacchi-Reggiani, A. Cuppini, E. Jovine, Hepatitis B and C virus infections as possible risk factor for pancreatic adenocarcinoma, Medical Hypotheses, 2012, 79, 5, 678

    CrossRef

  28. 28
    Tobias Flecken, Hans Christian Spangenberg, Robert Thimme, Immunobiology of hepatocellular carcinoma, Langenbeck's Archives of Surgery, 2012, 397, 5, 673

    CrossRef

  29. 29
    Kang-jie Chen, Lin Zhou, Hai-yang Xie, Taki-Eldin Ahmed, Xiao-wen Feng, Shu-sen Zheng, Intratumoral regulatory T cells alone or in combination with cytotoxic T cells predict prognosis of hepatocellular carcinoma after resection, Medical Oncology, 2012, 29, 3, 1817

    CrossRef

  30. 30
    E. Dvir, R.J. Mellanby, M. Kjelgaard-Hansen, J.P. Schoeman, Plasma IL-8 concentrations are increased in dogs with spirocercosis, Veterinary Parasitology, 2012, 190, 1-2, 185

    CrossRef

  31. 31
    Alka Mary Mathai, Monesh J. Kapadia, Jacob Alexander, Lauren E. Kernochan, Paul E. Swanson, Matthew M. Yeh, Role of Foxp3-positive Tumor-infiltrating Lymphocytes in the Histologic Features and Clinical Outcomes of Hepatocellular Carcinoma, The American Journal of Surgical Pathology, 2012, 36, 7, 980

    CrossRef

  32. 32
    Ken Shirabe, Yohei Mano, Jun Muto, Rumi Matono, Takashi Motomura, Takeo Toshima, Kazuki Takeishi, Hidekaki Uchiyama, Tomoharu Yoshizumi, Akinobu Taketomi, Masaru Morita, Shunichi Tsujitani, Yoshihisa Sakaguchi, Yoshihiko Maehara, Role of tumor-associated macrophages in the progression of hepatocellular carcinoma, Surgery Today, 2012, 42, 1, 1

    CrossRef

  33. 33
    Yaling Liu, Xin Xing, Juan Wang, Lingxiao Xing, Yanling Su, Zhigang Yao, Xia Yan, Junling Wang, Xianghong Zhang, Sterigmatocystin alters the number of FoxP3+ regulatory T cells and plasmacytoid dendritic cells in BALB/c mice, Food and Chemical Toxicology, 2012, 50, 6, 1920

    CrossRef

  34. 34
    Yong Huang, Feng-mei Wang, Tao Wang, Yi-jun Wang, Zheng-yan Zhu, Ying-tang Gao, Zhi Du, Tumor-Infiltrating FoxP3+ Tregs and CD8+ T Cells Affect the Prognosis of Hepatocellular Carcinoma Patients, Digestion, 2012, 86, 4, 329

    CrossRef

  35. 35
    Fangfang Liu, Ronggang Lang, Jing Zhao, Xinmin Zhang, Gordon A. Pringle, Yu Fan, Dong Yin, Feng Gu, Zhi Yao, Li Fu, CD8+ cytotoxic T cell and FOXP3+ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes, Breast Cancer Research and Treatment, 2011, 130, 2, 645

    CrossRef

  36. 36
    Takuro Saito, Takao Tsuchiya, Yoshihiro Sato, Akira Kenjo, Takashi Kimura, Takayuki Anazawa, Masanori Terashima, Atsushi Takahashi, Hiromasa Ohira, Mitsukazu Gotoh, Effect of Transarterial Immunoembolization as Preoperative Treatment for Hepatocellular Carcinoma, Annals of Cancer Research and Therapy, 2011, 19, 1, 26

    CrossRef

  37. 37
    Yoshiko Takata, Yasunari Nakamoto, Akiko Nakada, Takeshi Terashima, Fumitaka Arihara, Masaaki Kitahara, Kaheita Kakinoki, Kuniaki Arai, Taro Yamashita, Yoshio Sakai, Tatsuya Yamashita, Eishiro Mizukoshi, Shuichi Kaneko, Frequency of CD45RO+ subset in CD4+CD25high regulatory T cells associated with progression of hepatocellular carcinoma, Cancer Letters, 2011, 307, 2, 165

    CrossRef

  38. 38
    E. DVIR, J. P. SCHOEMAN, S. J. CLIFT, T. N. McNEILLY, R. J. MELLANBY, Immunohistochemical characterization of lymphocyte and myeloid cell infiltrates in spirocercosis-induced oesophageal nodules, Parasite Immunology, 2011, 33, 10
  39. 39
    Hyun-Tak Jin, Yun-Hee Jeong, Hyo-Jin Park, Sang-Jun Ha, Mechanism of T cell exhaustion in a chronic environment, BMB Reports, 2011, 44, 4, 217

    CrossRef

  40. 40
    CECILIA SÖDERBERG, JOEL MARMUR, KRISTINA ECKES, HANS GLAUMANN, MATTI SÄLLBERG, LARS FRELIN, PETER ROSENBERG, PER STÅL, ROLF HULTCRANTZ, Microvesicular fat, inter cellular adhesion molecule-1 and regulatory T-lymphocytes are of importance for the inflammatory process in livers with non-alcoholic steatohepatitis, APMIS, 2011, 119, 7
  41. 41
    Ekaterina Breous, Robert Thimme, Potential of immunotherapy for hepatocellular carcinoma, Journal of Hepatology, 2011, 54, 4, 830

    CrossRef

  42. 42
    Hui Liu, Li Xu, Jian-En Wei, Mei-Rong Xie, Shi-E Wang, Rui-Xiang Zhou, Role of CD4+CD25+ Regulatory T Cells in Melatonin-Mediated Inhibition of Murine Gastric Cancer Cell Growth In Vivo and In Vitro, The Anatomical Record, 2011, 294, 5
  43. 43
    Kai Yoshizawa, Hiroshi Abe, Yasuhito Kubo, Takuya Kitahara, Ryoichi Aizawa, Mika Matsuoka, Yoshio Aizawa, Expansion of CD4+CD25+FoxP3+ regulatory T cells in hepatitis C virus-related chronic hepatitis, cirrhosis and hepatocellular carcinoma, Hepatology Research, 2010, 40, 2
  44. 44
    Robert J. Clifford, Jinghui Zhang, Daoud M. Meerzaman, Myung-Soo Lyu, Ying Hu, Constance M. Cultraro, Richard P. Finney, Jenny M. Kelley, Sol Efroni, Sharon I. Greenblum, Cu V. Nguyen, William L. Rowe, Sweta Sharma, Gang Wu, Chunhua Yan, Hongen Zhang, Young-Hwa Chung, Jeong A. Kim, Neung Hwa Park, Il Han Song, Kenneth H. Buetow, Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma, Hepatology, 2010, 52, 6
  45. 45
    Roniel Cabrera, Miguel Ararat, Mengde Cao, Yiling Xu, Clive Wasserfall, Mark A. Atkinson, Chen Liu, David R. Nelson, Hepatocellular Carcinoma Immunopathogenesis: Clinical Evidence for Global T Cell Defects and an Immunomodulatory Role for Soluble CD25 (sCD25), Digestive Diseases and Sciences, 2010, 55, 2, 484

    CrossRef

  46. 46
    Shin Eun, Youn Kyung Jeon, Ja June Jang, Hepatocellular Carcinoma with Immature T-Cell (T-lymphoblastic) Proliferation, Journal of Korean Medical Science, 2010, 25, 2, 309

    CrossRef

  47. 47
    Firouzeh Korangy, Bastian Höchst, Michael P Manns, Tim F Greten, Immunotherapy of hepatocellular carcinoma, Expert Review of Gastroenterology & Hepatology, 2010, 4, 3, 345

    CrossRef

  48. 48
    Zhi-Qing Yang, Zhan-Yu Yang, Lei-Da Zhang, Ping-Bie, Shu-Guang Wang, Kuan-Sheng Ma, Xiao-Wu Li, Jia-Hong Dong, Increased liver-infiltrating CD8+FoxP3+ regulatory T cells are associated with tumor stage in hepatocellular carcinoma patients, Human Immunology, 2010, 71, 12, 1180

    CrossRef

  49. 49
    Ming-Chen Yang, Chih-Peng Chang, Huan-Yao Lei, Induction of liver fibrosis in a murine hepatoma model by thioacetamide is associated with enhanced tumor growth and suppressed antitumor immunity, Laboratory Investigation, 2010, 90, 12, 1782

    CrossRef

  50. 50
    Keisuke OTSUBO, Hirokazu KANEGANE, Ichiro KOBAYASHI, Toshio MIYAWAKI, IPEX syndrome and human Treg cells, Japanese Journal of Clinical Immunology, 2010, 33, 4, 196

    CrossRef

  51. 51
    Yuki Fujiwara, Hiroaki Shiba, Kenei Furukawa, Tomonori Iida, Taro Sakamoto, Takeshi Gocho, Shigeki Wakiyama, Shoichi Hirohara, Yuichi Ishida, Takeyuki Misawa, Toya Ohashi, Katsuhiko Yanaga, Perioperative change in white blood cell count predicts outcome of hepatic resection for hepatocellular carcinoma, Journal of Hepato-Biliary-Pancreatic Sciences, 2010, 17, 6
  52. You have free access to this content52
    H. H. Zhang, M. H. Mei, R. Fei, F. Liu, J. H. Wang, W. J. Liao, L. L. Qin, L. Wei, H. S. Chen, Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses, Journal of Viral Hepatitis, 2010, 17,
  53. 53
    Sergiusz Durowicz, Waldemar L. Olszewski, Magdalena Gewartowska, Marek Stańczyk, Justyna Stanisławska, Anna Wluka, Spleen migrating dendritic cells primed with CC531 colon cancer antigen and LPS – is it a method to compromise liver metastases?, Surgical Oncology, 2010, 19, 4, e85

    CrossRef

  54. 54
    Li ZHAO, De Kai QIU, Xiong MA, Th17 cells: The emerging reciprocal partner of regulatory T cells in the liver, Journal of Digestive Diseases, 2010, 11, 3
  55. 55
    Ken Shirabe, Takashi Motomura, Jun Muto, Takeo Toshima, Rumi Matono, Yohei Mano, Kazuki Takeishi, Hideki Ijichi, Noboru Harada, Hideaki Uchiyama, Tomoharu Yoshizumi, Akinobu Taketomi, Yoshihiko Maehara, Tumor-infiltrating lymphocytes and hepatocellular carcinoma: pathology and clinical management, International Journal of Clinical Oncology, 2010, 15, 6, 552

    CrossRef

  56. 56
    M.P. Holt, C. Ju, Comprehensive Toxicology, 2010,

    CrossRef

  57. 57
    D.-M. Kuang, Q. Zhao, C. Peng, J. Xu, J.-P. Zhang, C. Wu, L. Zheng, Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1, Journal of Experimental Medicine, 2009, 206, 6, 1327

    CrossRef

  58. 58
    Evangelia M Fatourou, John S Koskinas, Adaptive immunity in hepatocellular carcinoma: prognostic and therapeutic implications, Expert Review of Anticancer Therapy, 2009, 9, 10, 1499

    CrossRef

  59. 59
    Kouichi Momiyama, Hidenari Nagai, Yasukiyo Sumino, Changes of host immunity in relation to efficacy in liver cirrhosis patients with advanced hepatocellular carcinoma treated by intra-arterial chemotherapy, Cancer Chemotherapy and Pharmacology, 2009, 64, 2, 271

    CrossRef

  60. 60
    Marc-Oliver Riener, Peter J. Wild, Christopher Soll, Alexander Knuth, Boquan Jin, Achim Jungbluth, Claus Hellerbrand, Pierre-Alain Clavien, Holger Moch, Wolfram Jochum, Frequent expression of the novel cancer testis antigen MAGE-C2/CT-10 in hepatocellular carcinoma, International Journal of Cancer, 2009, 124, 2
  61. 61
    Ekaterina Breous, Suryanarayan Somanathan, Luk H. Vandenberghe, James M. Wilson, Hepatic regulatory T cells and Kupffer cells are crucial mediators of systemic T cell tolerance to antigens targeting murine liver, Hepatology, 2009, 50, 2
  62. 62
    Ho Sung Park, Kyu Yun Jang, Young Kon Kim, Baik Hwan Cho, Woo Sung Moon, Hepatocellular carcinoma with massive lymphoid infiltration: A regressing phenomenon?, Pathology - Research and Practice, 2009, 205, 9, 648

    CrossRef

  63. 63
    Jia Zhou, Tong Ding, Weidong Pan, Ling-yan Zhu, Lian Li, Limin Zheng, Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients, International Journal of Cancer, 2009, 125, 7
  64. 64
    Masahiro Kanayama, Hidenari Nagai, Yasukiyo Sumino, Influence of the etiology of liver cirrhosis on the response to combined intra-arterial chemotherapy in patients with advanced hepatocellular carcinoma, Cancer Chemotherapy and Pharmacology, 2009, 64, 1, 109

    CrossRef

  65. 65
    Kai-Fu Tang, Min Chen, Jing Xie, Guan-Bin Song, Yi-Song Shi, Qi Liu, Zhe-Chuan Mei, Alexander Steinle, Hong Ren, Inhibition of hepatitis B virus replication by small interference RNA induces expression of MICA in HepG2.2.15 cells, Medical Microbiology and Immunology, 2009, 198, 1, 27

    CrossRef

  66. 66
    A. Hosui, A. Kimura, D. Yamaji, B.-m. Zhu, R. Na, L. Hennighausen, Loss of STAT5 causes liver fibrosis and cancer development through increased TGF-  and STAT3 activation, Journal of Experimental Medicine, 2009, 206, 4, 819

    CrossRef

  67. 67
    Eszter Nemeth, Alan W. Baird, Cliona O’Farrelly, Microanatomy of the liver immune system, Seminars in Immunopathology, 2009, 31, 3, 333

    CrossRef

  68. 68
    Esther Unitt, William Gelson, Susan E. Davies, Nicholas Coleman, Graeme J. M. Alexander, Minichromosome maintenance protein-2–positive portal tract lymphocytes distinguish acute cellular rejection from hepatitis C virus recurrence after liver transplantation, Liver Transplantation, 2009, 15, 3
  69. 69
    Karim J. Halazun, Mark A. Hardy, Abbas A. Rana, David C. Woodland, Elijah J. Luyten, Suhari Mahadev, Piotr Witkowski, Abbey B. Siegel, Robert S. Brown, Jean C. Emond, Negative Impact of Neutrophil-Lymphocyte Ratio on Outcome After Liver Transplantation for Hepatocellular Carcinoma, Annals of Surgery, 2009, 250, 1, 141

    CrossRef

  70. 70
    Yan-Li Pang, Hua-Gang Zhang, Ji-Run Peng, Xue-Wen Pang, Shu Yu, Qiao Xing, Xin Yu, Lei Gong, Yan-Hui Yin, Yu Zhang, Wei-Feng Chen, The immunosuppressive tumor microenvironment in hepatocellular carcinoma, Cancer Immunology, Immunotherapy, 2009, 58, 6, 877

    CrossRef

  71. 71
    Ming-Hua Zheng, Dian-Na Gu, Martin Braddock, Andrew J Leishman, Chang Jin, Jin-Sheng Wen, Yue-Wen Gong, Yong-Ping Chen, CD4+CD25+regulatory T cells: a therapeutic target for liver diseases, Expert Opinion on Therapeutic Targets, 2008, 12, 3, 313

    CrossRef

  72. 72
    Bin Xiong, Gansheng Feng, Shihua Luo, Huimin Liang, Lingyun Qiu, Chuansheng Zheng, Xi Liu, Guofeng Zhou, Changes of CD4+ CD25+ regulatory T cells in peripheral blood in patients with hepatocellular carcinoma before and after TACE, Journal of Huazhong University of Science and Technology [Medical Sciences], 2008, 28, 6, 645

    CrossRef

  73. 73
    Robert Thimme, Michaela Neagu, Tobias Boettler, Christoph Neumann-Haefelin, Nadine Kersting, Michael Geissler, Frank Makowiec, Robert Obermaier, Ulrich T. Hopt, Hubert E. Blum, Hans Christian Spangenberg, Comprehensive analysis of the α-fetoprotein-specific CD8+ T cell responses in patients with hepatocellular carcinoma, Hepatology, 2008, 48, 6
  74. 74
    Petra Bochtler, Petra Riedl, Ivan Gomez, Reinhold Schirmbeck, Jörg Reimann, Local accumulation and activation of regulatory Foxp3+ CD4 TR cells accompanies the appearance of activated CD8 T cells in the liver, Hepatology, 2008, 48, 6
  75. 75
    Bertus Eksteen, James M Neuberger, Mechanisms of Disease: the evolving understanding of liver allograft rejection, Nature Clinical Practice Gastroenterology & Hepatology, 2008, 5, 4, 209

    CrossRef

  76. 76
    A. Sasaki, F. Tanaka, K. Mimori, H. Inoue, S. Kai, K. Shibata, M. Ohta, S. Kitano, M. Mori, Prognostic value of tumor-infiltrating FOXP3+ regulatory T cells in patients with hepatocellular carcinoma, European Journal of Surgical Oncology (EJSO), 2008, 34, 2, 173

    CrossRef

  77. 77
    J. Haas, L. Schopp, B. Storch-Hagenlocher, B. Fritzsching, C. Jacobi, L. Milkova, B. Fritz, A. Schwarz, E. Suri-Payer, M. Hensel, B. Wildemann, Specific recruitment of regulatory T cells into the CSF in lymphomatous and carcinomatous meningitis, Blood, 2008, 111, 2, 761

    CrossRef

  78. 78
    Hidenari Nagai, Daisuke Miyaki, Teppei Matsui, Masahiro Kanayama, Katsuya Higami, Kouichi Momiyama, Takashi Ikehara, Manabu Watanabe, Yasukiyo Sumino, Kazumasa Miki, Th1/Th2 balance: an important indicator of efficacy for intra-arterial chemotherapy, Cancer Chemotherapy and Pharmacology, 2008, 62, 6, 959

    CrossRef

  79. 79
    Xiong Ma, Jing Hua, Abdiaziz R. Mohamood, Abdel Rahmin A. Hamad, Rajani Ravi, Zhiping Li, A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury, Hepatology, 2007, 46, 5
  80. 80
    H. D. González, J. Figueras, Effect of surgical resection of metastatic disease on immune tolerance to cancer. How a systemic disease could be controlled by a local therapy, Clinical and Translational Oncology, 2007, 9, 9, 571

    CrossRef

  81. 81
    Mengde Cao, Roniel Cabrera, Yiling Xu, Roberto Firpi, Haizhen Zhu, Chen Liu, David R Nelson, Hepatocellular carcinoma cell supernatants increase expansion and function of CD4+CD25+ regulatory T cells, Laboratory Investigation, 2007,

    CrossRef

  82. 82
    Lian Li, Sheng-Ping Li, Jun Min, Limin Zheng, Hepatoma cells inhibit the differentiation and maturation of dendritic cells and increase the production of regulatory T cells, Immunology Letters, 2007, 114, 1, 38

    CrossRef

  83. 83
    Troy R. Torgerson, Hans D. Ochs, Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: Forkhead box protein 3 mutations and lack of regulatory T cells, Journal of Allergy and Clinical Immunology, 2007, 120, 4, 744

    CrossRef

  84. 84
    Junliang Fu, Dongping Xu, Zhenwen Liu, Ming Shi, Ping Zhao, Baoyun Fu, Zheng Zhang, Huiyin Yang, Hui Zhang, Chunbao Zhou, Jinxia Yao, Lei Jin, Huifen Wang, Yongping Yang, Yang-Xing Fu, Fu-Sheng Wang, Increased Regulatory T Cells Correlate With CD8 T-Cell Impairment and Poor Survival in Hepatocellular Carcinoma Patients, Gastroenterology, 2007, 132, 7, 2328

    CrossRef

  85. 85
    Hans D. Ochs, Eleonora Gambineri, Troy R. Torgerson, IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity, Immunologic Research, 2007, 38, 1-3, 112

    CrossRef

  86. 86
    Helen Y Wang, Rong-Fu Wang, Regulatory T cells and cancer, Current Opinion in Immunology, 2007, 19, 2, 217

    CrossRef

  87. 87
    D. Nummer, E. Suri-Payer, H. Schmitz-Winnenthal, A. Bonertz, L. Galindo, D. Antolovich, M. Koch, M. Buchler, J. Weitz, V. Schirrmacher, P. Beckhove, Role of Tumor Endothelium in CD4+CD25+ Regulatory T Cell Infiltration of Human Pancreatic Carcinoma, JNCI Journal of the National Cancer Institute, 2007, 99, 15, 1188

    CrossRef

  88. 88
    Simon M Rushbrook, Matthew Hoare, Graeme JM Alexander, T-regulatory lymphocytes and chronic viral hepatitis, Expert Opinion on Biological Therapy, 2007, 7, 11, 1689

    CrossRef

  89. 89
    Jun Yu, Targeting chemokines as a therapeutic option for hepatocellular carcinoma: A reality or just a fantasy?, Journal of Gastroenterology and Hepatology, 2007, 22, 5
  90. 90
    Yan-Shen Shan, Yu-Hsiang Hsieh, Pin-Wen Lin, Telomerase Activity in Tumor and Remnant Liver as Predictor of Recurrence and Survival in Hepatocellular Carcinoma after Resection, World Journal of Surgery, 2007, 31, 5, 1122

    CrossRef

  91. 91
    Alejandro Rodríguez-Molinero, María López-Diéguez, José R. Banegas, Tissue homeostasis and cancer, Medical Hypotheses, 2007, 68, 6, 1333

    CrossRef

  92. 92
    Keith L. Knutson, Mary L. Disis, Lupe G. Salazar, CD4 regulatory T cells in human cancer pathogenesis, Cancer Immunology, Immunotherapy, 2006, 56, 3, 271

    CrossRef

  93. 93
    Xiao-Yan Cai, Qiang Gao, Shuang-Jian Qiu, Sheng-Long Ye, Zhi-Quan Wu, Jia Fan, Zhao-You Tang, Dendritic cell infiltration and prognosis of human hepatocellular carcinoma, Journal of Cancer Research and Clinical Oncology, 2006, 132, 5, 293

    CrossRef

  94. 94
    SHENG-WEI YE, YU WANG, DANILA VALMORI, MAHA AYYOUB, YAN HAN, XIAO-LAN XU, AI-LIAN ZHAO, LI QU, SACHA GNJATIC, GERD RITTER, LLOYD J. OLD, JIN GU, Ex-Vivo Analysis of CD8+ T Cells Infiltrating Colorectal Tumors Identifies a Major Effector-Memory Subset with Low Perforin Content, Journal of Clinical Immunology, 2006, 26, 5, 447

    CrossRef

  95. 95
    Clare Baecher-Allan, David E Anderson, Immune regulation in tumor-bearing hosts, Current Opinion in Immunology, 2006, 18, 2, 214

    CrossRef

  96. 96
    Tim F. Greten, Michael P. Manns, Firouzeh Korangy, Immunotherapy of hepatocellular carcinoma, Journal of Hepatology, 2006, 45, 6, 868

    CrossRef

  97. 97
    Xiu Hua Yang, Satoshi Yamagiwa, Takafumi Ichida, Yasunobu Matsuda, Satoshi Sugahara, Hisami Watanabe, Yoshinobu Sato, Toru Abo, David A. Horwitz, Yutaka Aoyagi, Increase of CD4+CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma, Journal of Hepatology, 2006, 45, 2, 254

    CrossRef

  98. 98
    Caitriona Canning, Margaret O’Brien, John Hegarty, Cliona O’Farrelly, Liver immunity and tumour surveillance, Immunology Letters, 2006, 107, 2, 83

    CrossRef

  99. 99
    M. Rita I. Young, Protective mechanisms of head and neck squamous cell carcinomas from immune assault, Head & Neck, 2006, 28, 5
  100. 100
    Gareth J. Betts, Sarah L. Clarke, Hannah E. Richards, Andrew J. Godkin, Awen M. Gallimore, Regulating the immune response to tumours, Advanced Drug Delivery Reviews, 2006, 58, 8, 948

    CrossRef

  101. 101
    Clare Baecher-Allan, David E. Anderson, Regulatory cells and human cancer, Seminars in Cancer Biology, 2006, 16, 2, 98

    CrossRef

  102. 102
    Rimas J. Orentas, M. Eric Kohler, Bryon D. Johnson, Suppression of anti-cancer immunity by regulatory T cells: Back to the future, Seminars in Cancer Biology, 2006, 16, 2, 137

    CrossRef

  103. 103
    Giorgio Parmiani, Andrea Anichini, T cell infiltration and prognosis in HCC patients, Journal of Hepatology, 2006, 45, 2, 178

    CrossRef

  104. 104
    J C Steele, E E Torr, K L Noakes, E Kalk, P A Moss, G M Reynolds, S G Hubscher, M van Lohuizen, D H Adams, L S Young, The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigens, British Journal of Cancer, 2006, 95, 9, 1202

    CrossRef

  105. 105
    Shelly J. Robertson, Kim J. Hasenkrug, The role of virus-induced regulatory T cells in immunopathology, Springer Seminars in Immunopathology, 2006, 28, 1, 51

    CrossRef

  106. 106
    Esther Unitt, Aileen Marshall, William Gelson, Simon M. Rushbrook, Susan Davies, Sarah L. Vowler, Lesley S. Morris, Nicholas Coleman, Graeme J.M. Alexander, Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation, Journal of Hepatology, 2006, 45, 2, 246

    CrossRef

  107. 107
    Aniruddha Choudhury, Szilvia Mosolits, Parviz Kokhaei, Lotta Hansson, Marzia Palma, Håkan Mellstedt, 2006,

    CrossRef

  108. 108
    Kyong-Mi Chang, Regulatory T cells and the liver: A new piece of the puzzle, Hepatology, 2005, 41, 4